Search | WHO COVID-19 Research Database

Positive-strand RNA viruses-a Keystone Symposia report.

Cable, Jennifer; Denison, Mark R; Kielian, Margaret; Jackson, William T; Bartenschlager, Ralf; Ahola, Tero; Mukhopadhyay, Suchetana; Fremont, Daved H; Kuhn, Richard J; Shannon, Ashleigh; Frazier, Meredith N; Yuen, Kwok-Yung; Coyne, Carolyn B; Wolthers, Katja C; Ming, Guo-Li; Guenther, Camy S; Moshiri, Jasmine; Best, Sonja M; Schoggins, John W; Jurado, Kellie Ann; Ebel, Gregory D; Schäfer, Alexandra; Ng, Lisa F P; Kikkert, Marjolein; Sette, Alessandro; Harris, Eva; Wing, Peter A C; Eggenberger, Julie; Krishnamurthy, Siddharth R; Mah, Marcus G; Meganck, Rita M; Chung, Donghoon; Maurer-Stroh, Sebastian; Andino, Raul; Korber, Bette; Perlman, Stanley; Shi, Pei-Yong; Bárcena, Montserrat; Aicher, Sophie-Marie; Vu, Michelle N; Kenney, Devin J; Lindenbach, Brett D; Nishida, Yukiko; Rénia, Laurent; Williams, Evan P.

Ann N Y Acad Sci ; 1521(1): 46-66, 2023 03.

Article in English | MEDLINE | ID: covidwho-2228475

ABSTRACT

Positive-strand RNA viruses have been the cause of several recent outbreaks and epidemics, including the Zika virus epidemic in 2015, the SARS outbreak in 2003, and the ongoing SARS-CoV-2 pandemic. On June 18-22, 2022, researchers focusing on positive-strand RNA viruses met for the Keystone Symposium "Positive-Strand RNA Viruses" to share the latest research in molecular and cell biology, virology, immunology, vaccinology, and antiviral drug development. This report presents concise summaries of the scientific discussions at the symposium.

Subject(s)

COVID-19 , Zika Virus Infection , Zika Virus , Humans , SARS-CoV-2 , Positive-Strand RNA Viruses , Antiviral Agents/therapeutic use , Pandemics , Zika Virus Infection/epidemiology , Zika Virus Infection/prevention & control , Zika Virus Infection/drug therapy

ABSTRACT

Subject(s)

SEND TO:

SELECTION OF CITATIONS

SEARCH DETAIL